0.37
-0.235(-38.84%)
Currency In USD
| Previous Close | 0.61 |
| Open | 0.61 |
| Day High | 0.66 |
| Day Low | 0.35 |
| 52-Week High | 39.84 |
| 52-Week Low | 0.35 |
| Volume | 7.21M |
| Average Volume | 415,362 |
| Market Cap | 8.24M |
| PE | 0.13 |
| EPS | 2.88 |
| Moving Average 50 Days | 3.19 |
| Moving Average 200 Days | 7.8 |
| Change | -0.24 |
If you invested $1000 in Cyclacel Pharmaceuticals, Inc. (CYCC) 10 years ago, it would be worth $0.01 as of June 08, 2025 at a share price of $0.37. Whereas If you bought $1000 worth of Cyclacel Pharmaceuticals, Inc. (CYCC) shares 5 years ago, it would be worth $0.3 as of June 08, 2025 at a share price of $0.37.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
GlobeNewswire Inc.
Jun 03, 2025 8:15 PM GMT
KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has r
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT
GlobeNewswire Inc.
May 07, 2025 1:00 PM GMT
BERKELEY HEIGHTS, NJ, May 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implem
Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock
GlobeNewswire Inc.
Mar 24, 2025 11:30 AM GMT
KUALA LUMPUR, Malaysia, March 24, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has entered into a s